ASHM Report Back
Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.
Hepatitis Nursing Workshop
Professor Ed Gane says that there is no need for liver biopsy for assessing staging of hepatitis C in New Zealand.
The cost of the flight within New Zealand to a liver clinic with a fibroscan is justified, he believes.
Patients don't want a biopsy, and fibroscan has shown itself to be an effective tool for assessing fibrosis.